Jessica L. Mega - May 15, 2023 Form 4 Insider Report for DANAHER CORP /DE/ (DHR)

Role
Director
Signature
/s/ James F. O'Reilly, Attorney-in-Fact for Jessica L. Mega, MD, MPH
Stock symbol
DHR
Transactions as of
May 15, 2023
Transactions value $
$0
Form type
4
Date filed
5/17/2023, 05:03 PM
Previous filing
May 17, 2022
Next filing
Jun 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DHR Common Stock Award $0 +430 +26.19% $0.00 2.07K May 15, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DHR Director stock option (right to buy) Award $0 +1.19K $0.00 1.19K May 15, 2023 Common Stock 1.19K $226.94 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. The RSUs vest on the earlier of the first anniversary of the grant date, or the date of (and immediately prior to) the next annual meeting of Danaher's shareholders following the grant date, but the underlying shares are not issued until the earlier of the director's death or the first day of the seventh month following the director's retirement from the Board.